JP2024501581A5 - - Google Patents
Info
- Publication number
- JP2024501581A5 JP2024501581A5 JP2023558307A JP2023558307A JP2024501581A5 JP 2024501581 A5 JP2024501581 A5 JP 2024501581A5 JP 2023558307 A JP2023558307 A JP 2023558307A JP 2023558307 A JP2023558307 A JP 2023558307A JP 2024501581 A5 JP2024501581 A5 JP 2024501581A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- antibody
- sequence containing
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122714P | 2020-12-08 | 2020-12-08 | |
| US63/122,714 | 2020-12-08 | ||
| PCT/US2021/062099 WO2022125482A1 (en) | 2020-12-08 | 2021-12-07 | Antibodies to galectin-3 and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024501581A JP2024501581A (ja) | 2024-01-12 |
| JP2024501581A5 true JP2024501581A5 (https=) | 2024-12-16 |
| JP7825633B2 JP7825633B2 (ja) | 2026-03-06 |
Family
ID=81973696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558307A Active JP7825633B2 (ja) | 2020-12-08 | 2021-12-07 | ガレクチン－３に対する抗体及びその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240026009A1 (https=) |
| EP (1) | EP4259201A4 (https=) |
| JP (1) | JP7825633B2 (https=) |
| WO (1) | WO2022125482A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| CN118978593B (zh) * | 2023-11-07 | 2025-07-15 | 深圳市睿盟创新生物科技有限公司 | 人半乳糖凝集素-3蛋白水平的测定方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2972375A2 (en) * | 2013-03-13 | 2016-01-20 | Creatics LLC | Methods and compositions for detecting pancreatic cancer |
| WO2016073906A2 (en) * | 2014-11-06 | 2016-05-12 | Scholar Rock, Inc. | Transforming growth factor-related immunoassays |
| EP3303373B1 (en) * | 2015-05-30 | 2020-04-08 | Molecular Templates, Inc. | De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same |
| KR102293753B1 (ko) * | 2016-01-06 | 2021-08-24 | 오더-메이드 메디컬 리서치 인코포레이티드 | Vegf 와 nrp1 의 결합을 저해하는 항체 |
| CN111201030B (zh) * | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| EP3466975A1 (en) * | 2017-10-05 | 2019-04-10 | Laboratoire Français du Fractionnement et des Biotechnologies | A specific binding molecule directed against galectin-3 protein |
| AU2019215202B2 (en) * | 2018-02-01 | 2025-11-13 | Memorial Sloan Kettering Cancer Center | Antibodies to Galectin-3 and methods of use thereof |
| WO2020160156A2 (en) * | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
-
2021
- 2021-12-07 WO PCT/US2021/062099 patent/WO2022125482A1/en not_active Ceased
- 2021-12-07 US US18/256,384 patent/US20240026009A1/en active Pending
- 2021-12-07 JP JP2023558307A patent/JP7825633B2/ja active Active
- 2021-12-07 EP EP21904210.8A patent/EP4259201A4/en active Pending